These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. ONC201 in Combination with Paxalisib for the Treatment of H3K27-Altered Diffuse Midline Glioma. Jackson ER; Duchatel RJ; Staudt DE; Persson ML; Mannan A; Yadavilli S; Parackal S; Game S; Chong WC; Jayasekara WSN; Grand ML; Kearney PS; Douglas AM; Findlay IJ; Germon ZP; McEwen HP; Beitaki TS; Patabendige A; Skerrett-Byrne DA; Nixon B; Smith ND; Day B; Manoharan N; Nagabushan S; Hansford JR; Govender D; McCowage GB; Firestein R; Howlett M; Endersby R; Gottardo NG; Alvaro F; Waszak SM; Larsen MR; Colino-Sanguino Y; Valdes-Mora F; Rakotomalala A; Meignan S; Pasquier E; André N; Hulleman E; Eisenstat DD; Vitanza NA; Nazarian J; Koschmann C; Mueller S; Cain JE; Dun MD Cancer Res; 2023 May; ():OF1-OF17. PubMed ID: 37195023 [TBL] [Abstract][Full Text] [Related]
9. Preclinical and clinical evaluation of German-sourced ONC201 for the treatment of H3K27M-mutant diffuse intrinsic pontine glioma. Duchatel RJ; Mannan A; Woldu AS; Hawtrey T; Hindley PA; Douglas AM; Jackson ER; Findlay IJ; Germon ZP; Staudt D; Kearney PS; Smith ND; Hindley KE; Cain JE; André N; La Madrid AM; Nixon B; De Iuliis GN; Nazarian J; Irish K; Alvaro F; Eisenstat DD; Beck A; Vitanza NA; Mueller S; Morris JC; Dun MD Neurooncol Adv; 2021; 3(1):vdab169. PubMed ID: 34988452 [TBL] [Abstract][Full Text] [Related]
10. Decreased natural killer cells in diffuse intrinsic pontine glioma patients. Zhang L; Yu H; Xue Y; Liu Y Childs Nerv Syst; 2020 Jul; 36(7):1345-1346. PubMed ID: 32418048 [TBL] [Abstract][Full Text] [Related]
11. Reversal of cancer gene expression identifies repurposed drugs for diffuse intrinsic pontine glioma. Zhao G; Newbury P; Ishi Y; Chekalin E; Zeng B; Glicksberg BS; Wen A; Paithankar S; Sasaki T; Suri A; Nazarian J; Pacold ME; Brat DJ; Nicolaides T; Chen B; Hashizume R Acta Neuropathol Commun; 2022 Oct; 10(1):150. PubMed ID: 36274161 [TBL] [Abstract][Full Text] [Related]
12. ONC201 in combination with paxalisib for the treatment of H3K27-altered diffuse midline glioma. Jackson ER; Duchatel RJ; Staudt DE; Persson ML; Mannan A; Yadavilli S; Parackal S; Game S; Chong WC; Jayasekara WSN; Le Grand M; Kearney PS; Douglas AM; Findlay IJ; Germon ZP; McEwen HP; Beitaki TS; Patabendige A; Skerrett-Byrne DA; Nixon B; Smith ND; Day B; Manoharan N; Nagabushan S; Hansford JR; Govender D; McCowage GB; Firestein R; Howlett M; Endersby R; Gottardo NG; Alvaro F; Waszak SM; Larsen MR; Colino-Sanguino Y; Valdés-Mora F; Rakotomalala A; Meignan S; Pasquier E; Andre N; Hulleman E; Eisenstat DD; Vitanza NA; Nazarian J; Koschmann C; Mueller S; Cain JE; Dun MD Cancer Res; 2023 May; 83(14):2421-37. PubMed ID: 37145169 [TBL] [Abstract][Full Text] [Related]
13. Kluiver TA; Alieva M; van Vuurden DG; Wehrens EJ; Rios AC Front Oncol; 2020; 10():92. PubMed ID: 32117746 [TBL] [Abstract][Full Text] [Related]
14. Substrate Profiling of Mitochondrial Caseinolytic Protease P via a Site-Specific Photocrosslinking Approach. Nguyen TA; Gronauer TF; Nast-Kolb T; Sieber SA; Lang K Angew Chem Int Ed Engl; 2022 Mar; 61(10):e202111085. PubMed ID: 34847623 [TBL] [Abstract][Full Text] [Related]
15. Development of a human in vitro blood-brain tumor barrier model of diffuse intrinsic pontine glioma to better understand the chemoresistance. Deligne C; Hachani J; Duban-Deweer S; Meignan S; Leblond P; Carcaboso AM; Sano Y; Shimizu F; Kanda T; Gosselet F; Dehouck MP; Mysiorek C Fluids Barriers CNS; 2020 Jun; 17(1):37. PubMed ID: 32487241 [TBL] [Abstract][Full Text] [Related]
16. Polo-like Kinase 1 as a potential therapeutic target in Diffuse Intrinsic Pontine Glioma. Amani V; Prince EW; Alimova I; Balakrishnan I; Birks D; Donson AM; Harris P; Levy JM; Handler M; Foreman NK; Venkataraman S; Vibhakar R BMC Cancer; 2016 Aug; 16():647. PubMed ID: 27538997 [TBL] [Abstract][Full Text] [Related]
17. Monitoring of tumor growth and post-irradiation recurrence in a diffuse intrinsic pontine glioma mouse model. Caretti V; Zondervan I; Meijer DH; Idema S; Vos W; Hamans B; Bugiani M; Hulleman E; Wesseling P; Vandertop WP; Noske DP; Kaspers G; Molthoff CF; Wurdinger T Brain Pathol; 2011 Jul; 21(4):441-51. PubMed ID: 21159008 [TBL] [Abstract][Full Text] [Related]
18. Immunogenic Cell Death Enhances Immunotherapy of Diffuse Intrinsic Pontine Glioma: From Preclinical to Clinical Studies. Liu G; Qiu Y; Zhang P; Chen Z; Chen S; Huang W; Wang B; Yu X; Guo D Pharmaceutics; 2022 Aug; 14(9):. PubMed ID: 36145510 [TBL] [Abstract][Full Text] [Related]
19. Diffuse Intrinsic Pontine Glioma: From Diagnosis to Next-Generation Clinical Trials. Vitanza NA; Monje M Curr Treat Options Neurol; 2019 Jul; 21(8):37. PubMed ID: 31290035 [TBL] [Abstract][Full Text] [Related]
20. A phase I/II study of ribociclib following radiation therapy in children with newly diagnosed diffuse intrinsic pontine glioma (DIPG). DeWire M; Fuller C; Hummel TR; Chow LML; Salloum R; de Blank P; Pater L; Lawson S; Zhu X; Dexheimer P; Carle AC; Kumar SS; Drissi R; Stevenson CB; Lane A; Breneman J; Witte D; Jones BV; Leach JL; Fouladi M J Neurooncol; 2020 Sep; 149(3):511-522. PubMed ID: 33034839 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]